Company record
Sun Pharmaceutical Industries Limited
2 FDA warning letters since 2023 and 16 recalls in the last 12 months.
Get an email the day FDA posts anything new about Sun Pharmaceutical Industries Limited.
Warning letters
-
DrugsSun Pharmaceutical Industries Limited
CGMP/Finished Pharmaceuticals/Adulterated
-
DrugsSun Pharmaceutical Industries Ltd.
CGMP/Active Pharmaceutical Ingredient (API)/Adulterated
Recalls
| Reported | Class | Firm | Product and reason |
|---|---|---|---|
| Oct 14 | Class III | SUN PHARMACEUTICAL INDUSTRIES INC Drug |
Tretinoin Cream USP, 0.05%, 45 g tube, Manufactured for: Northstar Rx LLC, Memphis, TN 38141, Manufactured by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada L6T 1C1, Product of Canada, NDC 16714-249-02. Failed Impurities/Degradation Specifications |
| Oct 14 | Class III | SUN PHARMACEUTICAL INDUSTRIES INC Drug |
Tretinoin Cream UPS, 0.05%, 20g, Rx only, Mfd. by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada L6T 1C1, Dist. by: Taro Pharmaceuticals USA Inc., Hawthorne, NY 10532, NDC 51672-1394-0. Failed Impurities/Degradation Specifications |
| Oct 14 | Class III | SUN PHARMACEUTICAL INDUSTRIES INC Drug |
Tretinoin Cream USP, 0.05%, 45g tube, Rx only, Mfd by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada L6T 1C1, Dist. by: Taro Pharmaceuticals USA Inc., Hawthorne, NY 10532, NDC 51672-1394-9. Failed Impurities/Degradation Specifications |
| Aug 26 | Class II | SUN PHARMACEUTICAL INDUSTRIES INC Drug |
Carbamazepine Tablets, USP, 200mg, 1000 count bottles, Rx only, Manufactured by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel 2624761, Distributed by: Taro Pharmaceuticals USA, Inc., Hawthorne, NY 10532, NDC 51… CGMP Deviations; black spots found on tablets from burnt excipient during manufacturing |
| Jul 8 | Class III | SUN PHARMACEUTICAL INDUSTRIES INC Drug |
Fexofenadine Hydrochloride Tablets, USP 180 mg, Antihistamine, 150 Tablets per bottle, Distributed by: Ohm Laboratories, Inc., New Brunswick, NJ 08901. NDC 66336-561-30 Failed Impurities/Degradation Specifications |
| Jul 1 | Class II | SUN PHARMACEUTICAL INDUSTRIES INC Drug |
Perampanel CIII Tablets, 6mg, Rx only, 30 Tablets, Mfd.by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel 2624761, Dist. by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 51672-4206-6 Labeling: Label Mix-up: 10mg Perampanel CIII tablet was found in a Perampanel CIII bottle labeled Perampanel 6 mg tablets. |
| Jun 17 | Class II | SUN PHARMACEUTICAL INDUSTRIES INC Drug |
Budesonide Inhalation Suspension, 1mg/2mL, 30 x 2 mL Sterile Single-Dose Ampules (5 Single-Dose Ampules per pouch, 6 pouches per carton, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactur… Presence of Foreign Substance:This recall has been initiated in response to a product quality complaint reported for black/brown specs and particles within the ampoule solution |
| Jun 17 | Class I | SUN PHARMACEUTICAL INDUSTRIES INC Drug |
DOXOrubin Hydrochloride Liposome injection, 50 mg/25 mL (2mg/mL), 25 mL single-dose vials, Sterile, Rx only, Manufactured for: Northstar Rx LLC., Memphis, TN 38141, Manufactured by: Sun Pharmaceutical Ind. Ltd., Halol-Ba… Presence of Particulate matter: Particulate matter identified as glass. |
| Jun 10 | Class II | SUN PHARMACEUTICAL INDUSTRIES INC Drug |
Xyvona (levorphanol tartrate tablets), 2mg, 100 Tablets, Rx only, Forte BioPharma, Manufactured by: Ohm Laboratories Inc., New Brunswick, NJ 08901, Distributed by: Fort Bio-Pharma, LLC., Las Vegas, NV 89113, NDC 72245-76… Labeling: Not Elsewhere Classified. This recall has been initiated in response to the denial by FDA of marketing the product under the proprietary name Xyvona |
| Jun 10 | Class II | SUN PHARMACEUTICAL INDUSTRIES INC Drug |
Xyvona (levorphanol tartrate tablets), 3mg, 100 Tablets, Rx only, Forte BioPharma, Manufactured by: Ohm Laboratories Inc., New Brunswick, NJ 08901, Distributed by: Fort Bio-Pharma, LLC., Las Vegas, NV 89113, NDC 72245-05… Labeling: Not Elsewhere Classified. This recall has been initiated in response to the denial by FDA of marketing the product under the proprietary name Xyvona |
| Apr 22 | Class II | SUN PHARMACEUTICAL INDUSTRIES INC Drug |
Fluocinonide, USP, 0.05% Cream, 30g tube, Rx only, Mfd by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada L6T 1C1, Dist. by: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532, NDC 51672-1386-2. Failed Viscosity Specifications: Out of Specification results, above the specification limit, in viscosity, noted during stability testing. |
| Apr 22 | Class II | SUN PHARMACEUTICAL INDUSTRIES INC Drug |
Fluocinonide, USP, 0.05% Cream, 60g tube, Rx only, Mfd by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada L6T 1C1, Dist. by: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532, NDC 51672-1386-3. Failed Viscosity Specifications: Out of Specification results, above the specification limit, in viscosity, noted during stability testing. |
| Apr 22 | Class II | SUN PHARMACEUTICAL INDUSTRIES INC Drug |
Fluocinonide, USP, 0.05% Cream, 15g tube, Rx only, Mfd by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada L6T 1C1, Dist. by: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532, NDC 51672-1386-1 Failed Viscosity Specifications: Out of Specification results, above the specification limit, in viscosity, noted during stability testing. |
| Feb 11 | Class II | SUN PHARMACEUTICAL INDUSTRIES INC Drug |
Diclofenac Sodium, Topical Gel, 3%, 100 g tube, Rx only, Mfd. by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada L6T 1C1, Dist. by Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532, NDC 51672-1363-7 Failed Viscosity Specifications: Out of Specification (OOS) [slightly lower than the limit] result in viscosity for Diclofenac Sodium Gel, 3%. |
| Jan 21 | Class III | SUN PHARMACEUTICAL INDUSTRIES INC Drug |
Fluocinolone Acetonide Solution Topical Solution USP, 0.01%, 60-mL bottles, Rx only, Dist. by: Taro Pharmaceuticals Inc., Hawthorn, NY 10532. NDC 51672-1365-4 Failed Impurities/Degradation Specifications: Out of specification result was obtained for the known impurity D. |
| Jan 21 | Class III | SUN PHARMACEUTICAL INDUSTRIES INC Drug |
Clindamycin Phosphate USP, 1% (10 mg/mL), Topical Solution, 60 mL per applicator bottle, Rx only, Mfd. by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel; Dist. by: Taro Pharmaceuticals USA, Inc., Hawthorne, NY 1… Failed Impurities/Degradation: Out of Specification results for Total Impurities and for Assay. |